Examkin

Soru

Zorluk: OrtaGastroenterology and Hepatology

During an outpatient evaluation, a 4242-year-old male describes a one-year history of chronic watery diarrhea and burning epigastric pain that routinely awakens him from sleep. He has a history of multiple hospitalizations for complicated duodenal ulcers despite strict adherence to daily high-dose pantoprazole. Recent upper endoscopy revealed prominent hypertrophic gastric folds and multiple ulcerations extending into the distal duodenum and proximal jejunum. Histopathology from gastric biopsies was negative for *Helicobacter pylori* organisms. The clinician highly suspects an underlying neuroendocrine etiology.

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for the evaluation and management of this patient's suspected condition.

  1. 1Cessation of ongoing proton pump inhibitor therapy
  2. 2Assessment of fasting serum gastrin concentration and gastric pH
  3. 3Confirmatory biochemical evaluation via secretin stimulation testing
  4. 4Anatomic localization of the primary lesion using functional imaging
  5. 5Curative surgical resection of the identified neuroendocrine tumor

Cevap

The correct sequence for managing suspected Zollinger-Ellison syndrome is: 1) Discontinue proton pump inhibitors, 2) Measure fasting serum gastrin and gastric pH, 3) Perform a secretin stimulation test (if gastrin is indeterminate), 4) Localize the tumor via imaging, and 5) Perform surgical resection.
The algorithm for suspected Zollinger-Ellison syndrome (ZES) proceeds linearly from mitigating confounders to biochemical diagnosis, then to anatomic localization, and finally to definitive treatment. Proton pump inhibitors must first be stopped to prevent false-positive gastrin elevations. Fasting serum gastrin and gastric pH are measured as the initial screen. If gastrin is elevated but <1000 pg/mL< 1000\text{ pg/mL}, a secretin stimulation test confirms the diagnosis. Only after biochemical confirmation is functional imaging (DOTATATE PET/CT) utilized to find the tumor, followed by surgical resection for sporadic cases.

Adım Adım Çözüm

1
Identify the suspected clinical diagnosis based on the vignette.
Zollinger-Ellison syndrome (ZES) secondary to a gastrinoma.
The patient has multiple, refractory peptic ulcers in atypical locations (distal duodenum, jejunum), prominent gastric folds, and chronic watery diarrhea.
2
Determine the necessary prerequisite for biochemical testing.
Discontinuation of proton pump inhibitor (PPI) therapy.
PPIs induce physiologic hypergastrinemia by abolishing gastric acid, confounding diagnostic laboratory tests. They must be stopped (often transitioning to H2 blockers temporarily) before drawing labs.
3
Establish the initial biochemical evidence of the disease.
Measurement of fasting serum gastrin and concurrent gastric pH.
Simultaneous elevation of gastrin with profound gastric acidity (pH<2\text{pH} < 2) demonstrates autonomous gastrin secretion.
4
Confirm the diagnosis if initial lab results are equivocal.
Administration of a secretin stimulation test.
Secretin normally inhibits gastrin release, but in patients with a gastrinoma, it paradoxically stimulates a dramatic rise in serum gastrin levels.
5
Locate the tumor anatomically.
Functional imaging (e.g., Somatostatin receptor scintigraphy or DOTATATE PET/CT).
Localization is only indicated after biochemical confirmation to avoid the pursuit of clinically insignificant incidentalomas.
6
Determine the definitive therapeutic intervention.
Surgical resection.
For sporadic gastrinomas without evidence of widespread metastatic disease, surgical excision provides the only chance for a definitive cure.

Anahtar Kavram

The stepwise evaluation of Zollinger-Ellison syndrome mandates establishing a definitive biochemical diagnosis (off PPI therapy) prior to anatomic localization and surgical intervention.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru